Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck EBITDA 2010-2023 | MKGAF

Merck annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Merck EBITDA for the quarter ending December 31, 2023 was $1.208B, a 24.54% decline year-over-year.
  • Merck EBITDA for the twelve months ending December 31, 2023 was $5.942B, a 13.29% decline year-over-year.
  • Merck 2023 annual EBITDA was $5.942B, a 13.29% decline from 2022.
  • Merck 2022 annual EBITDA was $6.853B, a 2.49% decline from 2021.
  • Merck 2021 annual EBITDA was $7.028B, a 24.97% increase from 2020.
  
Merck Annual EBITDA
(Millions of US $)
2023 $5,942
2022 $6,853
2021 $7,028
2020 $5,624
2019 $4,552
2018 $4,178
2017 $4,841
2016 $4,887
2015 $3,722
2014 $4,151
2013 $4,830
2012 $3,780
2011 $1,555
2010 $12,338
2009 $10,807
Merck Quarterly EBITDA
(Millions of US $)
2023-12-31 $1,208
2023-09-30 $1,543
2023-06-30 $1,591
2023-03-31 $1,600
2022-12-31 $1,601
2022-09-30 $1,662
2022-06-30 $1,791
2022-03-31 $1,799
2021-12-31 $1,753
2021-09-30 $1,738
2021-06-30 $1,768
2021-03-31 $1,769
2020-12-31 $1,244
2020-09-30 $1,958
2020-06-30 $1,156
2020-03-31 $1,265
2019-12-31 $1,202
2019-09-30 $1,183
2019-06-30 $1,199
2019-03-31 $968
2018-12-31 $985
2018-09-30 $1,042
2018-06-30 $987
2018-03-31 $1,164
2017-12-31 $822
2017-09-30 $1,613
2017-06-30 $1,124
2017-03-31 $1,282
2016-12-31 $1,027
2016-09-30 $1,226
2016-06-30 $1,220
2016-03-31 $1,414
2015-12-31 $886
2015-09-30 $1,023
2015-06-30 $926
2015-03-31 $941
2014-12-31 $620
2014-09-30 $1,009
2014-06-30 $952
2014-03-31 $1,057
2013-12-31 $1,155
2013-09-30 $1,259
2013-06-30 $1,292
2013-03-31 $1,111
2012-12-31 $3,646
2012-09-30 $601
2012-06-30 $79
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $151
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $618
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $21.118B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.648B 31.17
Chugai Pharmaceutical (CHGCY) Japan $57.871B 25.87
Takeda Pharmaceutical (TAK) Japan $41.080B 8.32
Astellas Pharma (ALPMY) Japan $17.771B 28.06
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
United Therapeutics (UTHR) United States $14.151B 15.09
Neurocrine Biosciences (NBIX) United States $13.594B 37.21
Shionogi (SGIOY) Japan $11.423B 9.93
Catalent (CTLT) United States $10.160B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.208B 0.00
Ionis Pharmaceuticals (IONS) United States $6.860B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.816B 7.49
Revolution Medicines (RVMD) United States $6.406B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.968B 0.00
Summit Therapeutics (SMMT) United States $5.623B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.538B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.337B 0.00
Corcept Therapeutics (CORT) United States $3.164B 28.67
Dyne Therapeutics (DYN) United States $2.963B 0.00
PTC Therapeutics (PTCT) United States $2.696B 0.00
Indivior (INDV) United States $2.245B 10.64
Recursion Pharmaceuticals (RXRX) United States $2.229B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.006B 11.40
Catalyst Pharmaceuticals (CPRX) United States $1.789B 17.41
NewAmsterdam Pharma (NAMS) Netherlands $1.770B 0.00
Evotec AG (EVO) Germany $1.673B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.615B 24.28
Ardelyx (ARDX) United States $1.401B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.374B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.56
Soleno Therapeutics (SLNO) United States $1.301B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.255B 0.00
Xencor (XNCR) United States $1.193B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.157B 0.00
4D Molecular Therapeutics (FDMT) United States $1.137B 0.00
Collegium Pharmaceutical (COLL) United States $1.031B 6.17
Ocular Therapeutix (OCUL) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.010B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.966B 15.05
Cassava Sciences (SAVA) United States $0.925B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.893B 0.00
Cronos Group (CRON) Canada $0.867B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.795B 0.00
Harrow (HROW) United States $0.766B 0.00
ARS Pharmaceuticals (SPRY) United States $0.741B 0.00
Sage Therapeutics (SAGE) United States $0.656B 0.00
Exscientia (EXAI) United Kingdom $0.639B 0.00
Silence Therapeutics (SLN) United Kingdom $0.597B 0.00
Lexeo Therapeutics (LXEO) United States $0.556B 0.00
Altimmune (ALT) United States $0.525B 0.00
Savara (SVRA) United States $0.525B 0.00
Siga Technologies (SIGA) United States $0.524B 6.70
Lyell Immunopharma (LYEL) United States $0.520B 0.00
ProKidney (PROK) United States $0.511B 0.00
KalVista Pharmaceuticals (KALV) United States $0.487B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.474B 0.00
Heron Therapeutics (HRTX) United States $0.459B 0.00
Larimar Therapeutics (LRMR) United States $0.449B 0.00
OmniAb (OABI) United States $0.446B 0.00
Verve Therapeutics (VERV) United States $0.439B 0.00
Bioventus (BVS) United States $0.434B 16.61
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.364B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Xeris Biopharma Holdings (XERS) United States $0.311B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.299B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Century Therapeutics (IPSC) United States $0.216B 0.00
ESSA Pharma (EPIX) Canada $0.215B 0.00
Incannex Healthcare (IXHL) Australia $0.214B 0.00
Eliem Therapeutics (ELYM) United States $0.213B 0.00
Aquestive Therapeutics (AQST) United States $0.210B 0.00
Prelude Therapeutics (PRLD) United States $0.208B 0.00
Fractyl Health (GUTS) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Elite Pharmaceuticals (ELTP) United States $0.195B 18.28
Zevra Therapeutics (ZVRA) United States $0.192B 0.00
Acrivon Therapeutics (ACRV) United States $0.187B 0.00
Pyxis Oncology (PYXS) United States $0.180B 0.00
Akebia Therapeutics (AKBA) United States $0.180B 0.00
Adherex Technologies (FENC) United States $0.169B 206.67
Context Therapeutics (CNTX) United States $0.164B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.148B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.140B 0.00
Metagenomi (MGX) United States $0.140B 0.00
Galectin Therapeutics (GALT) United States $0.139B 0.00
CytoDyn (CYDY) United States $0.137B 0.00
Karyopharm Therapeutics (KPTI) United States $0.136B 0.00
MediWound (MDWD) Israel $0.136B 0.00
Telomir Pharmaceuticals (TELO) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.126B 8.41
VAXART, INC (VXRT) United States $0.122B 0.00
Citius Pharmaceuticals (CTXR) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.114B 5.22
Journey Medical (DERM) United States $0.100B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Conduit Pharmaceuticals (CDT) United States $0.091B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.071B 1.01
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Nutriband (NTRB) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Carisma Therapeutics (CARM) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
DURECT (DRRX) United States $0.044B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Talphera (TLPH) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.05
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 29.19